Cardiff Oncology (CRDF) Long-Term Debt Issuances (2016)

Cardiff Oncology (CRDF) has disclosed Long-Term Debt Issuances for 5 consecutive years, with $7.0 million as the latest value for Q4 2016.

  • Quarterly Long-Term Debt Issuances rose 545.71% to $7.0 million in Q4 2016 from the year-ago period, while the trailing twelve-month figure was $7.0 million through Sep 2017, up 273.36% year-over-year, with the annual reading at $305000.0 for FY2020, N/A changed from the prior year.
  • Long-Term Debt Issuances hit $7.0 million in Q4 2016 for Cardiff Oncology, up from $241954.0 in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $14.5 million in Q2 2014 to a low of -$2.0 million in Q2 2013.
  • Historically, Long-Term Debt Issuances has averaged $2.2 million across 5 years, with a median of $1.1 million in 2015.
  • Biggest five-year swings in Long-Term Debt Issuances: plummeted 186.5% in 2013 and later skyrocketed 1672.38% in 2015.
  • Year by year, Long-Term Debt Issuances stood at $2.3 million in 2012, then plummeted by 91.4% to $200796.0 in 2013, then tumbled by 69.48% to $61277.0 in 2014, then surged by 1672.38% to $1.1 million in 2015, then soared by 545.71% to $7.0 million in 2016.
  • Business Quant data shows Long-Term Debt Issuances for CRDF at $7.0 million in Q4 2016, $241954.0 in Q2 2016, and $550297.0 in Q1 2016.